[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 108(12S): S53-S64, 2021 Dec.
Article
in Fr
| MEDLINE
| ID: mdl-34253335
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Monitoring, Immunologic
/
Immunotherapy, Adoptive
/
Hematologic Neoplasms
/
Immune Reconstitution
Type of study:
Etiology_studies
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
Fr
Journal:
Bull Cancer
Year:
2021
Document type:
Article
Country of publication:
Francia